(Press-News.org) CLEVELAND—A groundbreaking study by researchers at Case Western Reserve University suggests a class of medications used to treat type 2 diabetes may also reduce the risk of colorectal cancer (CRC).
The findings, published today (Dec. 7) in the journal JAMA Oncology, support the need for clinical trials to determine whether these medications could prevent one of the deadliest types of cancers. Eventually, the medications may also show promise in warding off other types of cancer associated with obesity and diabetes.
“Our results clearly demonstrate that GLP-1 RAs are significantly more effective than popular anti-diabetic drugs, such as Metformin or insulin, at preventing the development of CRC,” said Nathan Berger, the Hanna-Payne Professor of Experimental Medicine at the Case Western Reserve School of Medicine and the study’s co-lead researcher.
Glucagon-like peptide-1 receptor agonists, or GLP-1 RAs, are medications to treat type 2 diabetes. Usually given by injection, they can lower blood-sugar levels, improve insulin sensitivity and help manage weight. They’ve also been shown to reduce the rates of major cardiovascular ailments.
Importantly the protective effect of GLP-1 RAs are noted in patients with or without overweight/obesity.
“To our knowledge,” said co-lead researcher Rong Xu, a professor at the School of Medicine, “this is the first indication this popular weight-loss and anti-diabetic class of drugs reduces incidence of CRC, relative to other anti-diabetic agents.”
Berger and Xu are members of the Case Comprehensive Cancer Center.
National health problem
Being overweight or obese or having diabetes are risk factors for increasing incidence of CRC and for making its prognosis worse.
The National Institutes of Health (NIH) defines being overweight and obese as an increase in size and amount of fat cells in the body above certain levels. These conditions are common nationally and are caused by several factors—among them diet, lack of sleep or physical activity, genetics and family history.
Healthcare providers use body mass index to measure body fat based on height and weight. Nearly 75% of adults ages 20 or older in the United States are either overweight or obese, and nearly 20% of children and teens ages 2 to 19 have obesity, according to the NIH.
Obesity is a chronic health condition that raises the risk for heart disease—the leading cause of death in the United States—and is linked to many other health problems, including type 2 diabetes and cancer.
The American Cancer Society estimates CRC is the third-leading type of cancer in both sexes, with 153,000 new cases per year. It is also the second-leading cause of cancer mortality with 52,550 deaths per year.
The study
Since GLP-1 RAs have been shown to be effective anti-diabetic and weight-loss agents, the researchers hypothesized they might reduce incidence of CRC.
Using a national database of more than 100 million electronic health records, the researchers conducted a population-based study of more than 1.2 million patients. These individuals had been treated with anti-diabetic agents from 2005-19; the CWRU team examined the effects of GLP-1 RAs on their incidence of CRC, as compared to those prescribed other anti-diabetic drugs.
Population-based research means matching as many people as possible with the same characteristics—sex, race, age, socio-economic determinants of health and other medical conditions—to accurately compare the drug’s effects.
Among 22,572 patients with diabetes treated with insulin, there were 167 cases of CRC. Another 22,572 matched patients treated with GLP-1 RAs saw 94 cases of CRC. Those treated with GLP-1 RAs had a 44% reduction in incidence of CRC.
In a similar comparison of 18,518 patients with diabetes treated with Metformin, compared to 18,518 patients with diabetes treated with GLP-1 RAs, had a 25% reduction in CRC.
“The research is critically important for reducing incidence of CRC in patients with diabetes, with or without overweight and obesity,” Berger said.
***
(Initial data for this manuscript was developed last summer by Lindsey Wang and William Wang, Orange High School students whose work was sponsored by the Case Comprehensive Cancer Center and National Cancer Institute-funded Scientific Enrichment Opportunity/Youth Engaged in Science Program. Lindsey Wang is now a first-year undergraduate at Case Western Reserve in the pre-professional scholars program, planning to enroll at the Case Western Reserve School of Medicine.)
###
Case Western Reserve University is one of the country's leading private research institutions. Located in Cleveland, we offer a unique combination of forward-thinking educational opportunities in an inspiring cultural setting. Our leading-edge faculty engage in teaching and research in a collaborative, hands-on environment. Our nationally recognized programs include arts and sciences, dental medicine, engineering, law, management, medicine, nursing and social work. About 6,200 undergraduate and 6,100 graduate students comprise our student body. Visit case.edu to see how Case Western Reserve thinks beyond the possible.
END
New Case Western Reserve University study finds diabetes drug may reduce risk for colorectal cancer
2023-12-07
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Ecology: Mediterranean green turtles nesting range expands under warming climate
2023-12-07
Rising global temperatures could lead to an increase in the nesting range of green turtles in the Mediterranean Sea, according to a modelling study published in Scientific Reports. Under the worst-case climate scenario, the nesting range could increase by over 60 percentage points, spreading west from the current area to include much of the North African, Italian, and Greek coastlines.
Human-caused climate change has caused sea surface temperatures to increase globally, with severe impacts on some marine life. Sea turtles are potentially particularly susceptible, as the sex of their offspring is dependent on incubation temperature. Although previous research ...
Racial and ethnic disparities in clinical trial enrollment among women with gynecologic cancer
2023-12-07
About The Study: Clinical trial enrollment was lower among certain minoritized racial and ethnic groups in this study of 562,000 women with endometrial, ovarian, or cervical cancer. Continued efforts are needed to address disparate clinical trial enrollment among underrepresented groups.
Authors: Ashley S. Felix, Ph.D., of Ohio State University in Columbus, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2023.46494)
Editor’s ...
Opioid prescribing by surgeons
2023-12-07
About The Study: This study found that during 2016 to 2022, the rate and size of opioid prescriptions from U.S. surgeons declined, but these declines were slower after mid-2020 compared with before 2020. During the initial months of the COVID-19 pandemic, the opioid dispensing rate declined, potentially owing to decreased surgical volume, while opioid prescription size increased, potentially because surgeons wrote larger discharge prescriptions owing to barriers to obtaining refills. However, these changes were transient.
Authors: Kao-Ping ...
Improving prediction of advanced breast cancer among women of different races and ethnicities
2023-12-07
While regular screenings may decrease the chance of diagnosis of advanced breast cancer in some women and lead to a 20% reduction in breast cancer mortality, other women will be diagnosed with advanced breast cancer despite screening at regular intervals. The chances of being diagnosed with advanced breast cancer are higher among women who are Black or Hispanic/Latinx as well as women who are overweight and obese.
In a study publishing December 7, 2023 in JAMA Oncology, UC San Francisco researchers found that regular screening is not always sufficient to prevent an advanced breast cancer diagnosis. To reduce the number of advanced cancer diagnoses, ...
Surgery patients now less likely to get opioids – but decline has slowed
2023-12-07
Post-surgery pain relief has shifted away from opioid-containing medications over the past seven years, but the downward trend has slowed since 2020, a new study shows.
Overall, the rate of surgery-related opioid prescriptions dropped by 36% from 2016 to the end of 2022, and the average amount of opioids in those prescriptions dropped by 46%, the study of pharmacy data finds.
That combination of declines means that the total amount of opioids dispensed to surgical patients in late 2022 was 66% lower compared with early 2016, according to the findings published in JAMA Network Open by a team from the University of Michigan.
But the rate of decline was much faster before the pandemic, ...
Three-day exceptional heatwave in China linked to human-induced climate change
2023-12-07
In June, temperatures in North China hit record breaking heights, with temperatures in Beijing reaching or exceeding 40℃ for three consecutive days.
The intensity of such events has increased by at least 1.0℃ due to human-induced climate change.
Heatwaves like these will occur twice as likely even under proposed carbon neutral targets and will be 0.5℃ more intense.
Current emissions scenario will increase the probability of reoccurrence to over five times this century with a 2.9℃ rise in intensity.
A record-breaking heatwave occurred in North China in June, marking the ...
Patients who speak Spanish, identify as Hispanic or experience food and housing insecurity at increased risk for depression, anxiety during radiation treatment
2023-12-07
(Boston)—Depression and anxiety among people living with a cancer diagnosis is a growing clinical and research priority. However, the prevalence of mood disorders in those living with cancer varies due to a multitude of variables such as stage and type of cancer, treatment, age, race and ethnicity.
A new study by researchers at Boston University Chobanian & Avedisian School of Medicine has found that Spanish-speaking patients undergoing radiotherapy for breast cancer experienced higher distress levels at baseline compared to English-speakers and that this distress increased over ...
WIC participation helped families better cope with 2022 infant formula shortage
2023-12-07
SPOKANE, Wash. – Families that participated in the WIC program—also known as the Special Supplemental Nutrition Program for Women, Infants and Children—were much less likely to use potentially unsafe infant feeding practices during the 2022 U.S. infant formula shortage than income-eligible families that did not participate.
Both WIC participants and non-participants reported being affected by the shortage at similar rates, according to a Washington State University study published in the Journal of the Academy of Nutrition and ...
Early life gene epimutation may cause breast cancer.
2023-12-07
Research reveals that around 20 per cent of all cases of the most severe form of breast cancer may arise from the small group of normal tissue cells carrying an epimutation of a specific gene.Research reveals that around 20 per cent of all cases of the most severe form of breast cancer may arise from the small group of normal tissue cells carrying an epimutation of a specific gene.
Cancer is a major health challenge worldwide, affecting many lives. Despite progress in understanding its causes, most cancer forms, including breast cancer, continues to increase in ...
The mechanism of ferroptosis and its related diseases
2023-12-07
In a groundbreaking review titled "The Mechanism of Ferroptosis and its Related Diseases," Feng and his colleagues from the Department of Urology and the Institute of Urology, State Key Laboratory of Biotherapy, and Cancer Center at West China Hospital, Sichuan University, have undertaken a comprehensive investigation of ferroptosis and its intricate relationships with various diseases. This review not only discusses the mechanisms of ferroptosis and its associations with diseases but also underscores the pivotal role of compounds in targeting this regulated cell death process for therapeutic applications.
Ferroptosis, initially identified by Dr. Brent R. Stockwell in 2012, gained ...